PRe-exposure Option for reducing HIV in the UK: an open-label randomisation to immediate or Deferred daily Truvada for HIV negative gay men

Registry ID

EUCTR2012-002373-56

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

Medical Research Council

Start date

2012-09-18

Completion date

2016-10-28

Last update

2026-08-16

Conditions

• HIV infection

Summary

The purpose of this pilot is to determine whether it is feasibile to conduct a large trial in the UK to determine whether the immediate inclusion of anti-retroviral pre-exposure prophylaxis (PrEP) as part of the HIV risk reduction package for men who have sex with men is clinically effective and cost-effective in reducing the risk of acquiring HIV.

Locations

• , , UK

View on source registry